Correction
Published on 28 Apr 2026
Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
- 191 views
Correction
Published on 28 Apr 2026
in Multiple Sclerosis and Neuroimmunology
Clinical Trial
Published on 28 Apr 2026
in Neurorehabilitation
Original Research
Published on 28 Apr 2026
in Bilingualism
Original Research
Published on 28 Apr 2026
in Mental Health and Wellbeing in Education
Original Research
Published on 28 Apr 2026
in Reproduction
Original Research
Published on 28 Apr 2026
in Construction Management
Mini Review
Published on 28 Apr 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 28 Apr 2026
in Pathology
Brief Research Report
Published on 28 Apr 2026
in Neuroendocrine Science
Review
Published on 28 Apr 2026
in Nutritional Immunology
Original Research
Published on 28 Apr 2026
in Life-Course Epidemiology and Social Inequalities in Health
Original Research
Published on 28 Apr 2026
in Quantitative Sustainability Assessment
Original Research
Published on 28 Apr 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 28 Apr 2026
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 28 Apr 2026
in Construction Materials
Review
Published on 28 Apr 2026
in Bone Research